Cornelia M. Ulrich
The Cancer Prevention Program
Fred Hutchinson Cancer Research Center
Seattle
Washington 98109
USA
Name/email consistency: high
- Modeling folate, one-carbon metabolism, and DNA methylation. Ulrich, C.M., Reed, M.C., Nijhout, H.F. Nutr. Rev. (2008)
- Folate and cancer prevention--where to next? Counterpoint. Ulrich, C.M. Cancer Epidemiol. Biomarkers Prev. (2008)
- Mathematical modeling of folate metabolism: predicted effects of genetic polymorphisms on mechanisms and biomarkers relevant to carcinogenesis. Ulrich, C.M., Neuhouser, M., Liu, A.Y., Boynton, A., Gregory, J.F., Shane, B., James, S.J., Reed, M.C., Nijhout, H.F. Cancer Epidemiol. Biomarkers Prev. (2008)
- Non-steroidal anti-inflammatory drugs for cancer prevention: promise, perils and pharmacogenetics. Ulrich, C.M., Bigler, J., Potter, J.D. Nat. Rev. Cancer (2006)
- Folate supplementation: too much of a good thing?. Ulrich, C.M., Potter, J.D. Cancer Epidemiol. Biomarkers Prev. (2006)
- PTGS2 (COX-2) -765G > C promoter variant reduces risk of colorectal adenoma among nonusers of nonsteroidal anti-inflammatory drugs. Ulrich, C.M., Whitton, J., Yu, J.H., Sibert, J., Sparks, R., Potter, J.D., Bigler, J. Cancer Epidemiol. Biomarkers Prev. (2005)
- Thromboxane synthase (TBXAS1) polymorphisms in African-American and Caucasian populations: evidence for selective pressure. Ulrich, C.M., Carlson, C.S., Sibert, J., Poole, E.M., Yu, J.H., Wang, L.H., Sparks, R., Potter, J.D., Bigler, J. Hum. Mutat. (2005)
- MTHFR variants reduce the risk of G:C->A:T transition mutations within the p53 tumor suppressor gene in colon tumors. Ulrich, C.M., Curtin, K., Samowitz, W., Bigler, J., Potter, J.D., Caan, B., Slattery, M.L. J. Nutr. (2005)
- Nutrigenetics in cancer research--folate metabolism and colorectal cancer. Ulrich, C.M. J. Nutr. (2005)
- Polymorphisms in the reduced folate carrier, thymidylate synthase, or methionine synthase and risk of colon cancer. Ulrich, C.M., Curtin, K., Potter, J.D., Bigler, J., Caan, B., Slattery, M.L. Cancer Epidemiol. Biomarkers Prev. (2005)
- Polymorphisms in PTGS1 (=COX-1) and risk of colorectal polyps. Ulrich, C.M., Bigler, J., Sparks, R., Whitton, J., Sibert, J.G., Goode, E.L., Yasui, Y., Potter, J.D. Cancer Epidemiol. Biomarkers Prev. (2004)
- Cancer pharmacogenetics: polymorphisms, pathways and beyond. Ulrich, C.M., Robien, K., McLeod, H.L. Nat. Rev. Cancer (2003)
- Pharmacogenetics and folate metabolism -- a promising direction. Ulrich, C.M., Robien, K., Sparks, R. Pharmacogenomics (2002)
- Thymidylate synthase promoter polymorphism, interaction with folate intake, and risk of colorectal adenomas. Ulrich, C.M., Bigler, J., Bostick, R., Fosdick, L., Potter, J.D. Cancer Res. (2002)
- Cyclooxygenase 1 (COX1) polymorphisms in African-American and Caucasian populations. Ulrich, C.M., Bigler, J., Sibert, J., Greene, E.A., Sparks, R., Carlson, C.S., Potter, J.D. Hum. Mutat. (2002)
- Pharmacogenetics of methotrexate: toxicity among marrow transplantation patients varies with the methylenetetrahydrofolate reductase C677T polymorphism. Ulrich, C.M., Yasui, Y., Storb, R., Schubert, M.M., Wagner, J.L., Bigler, J., Ariail, K.S., Keener, C.L., Li, S., Liu, H., Farin, F.M., Potter, J.D. Blood (2001)
- Epoxide hydrolase Tyr113His polymorphism is associated with elevated risk of colorectal polyps in the presence of smoking and high meat intake. Ulrich, C.M., Bigler, J., Whitton, J.A., Bostick, R., Fosdick, L., Potter, J.D. Cancer Epidemiol. Biomarkers Prev. (2001)
- Searching expressed sequence tag databases: discovery and confirmation of a common polymorphism in the thymidylate synthase gene. Ulrich, C.M., Bigler, J., Velicer, C.M., Greene, E.A., Farin, F.M., Potter, J.D. Cancer Epidemiol. Biomarkers Prev. (2000)